342 related articles for article (PubMed ID: 29443901)
1. Toxicology of Engineered Nanoparticles: Focus on Poly(amidoamine) Dendrimers.
Naha PC; Mukherjee SP; Byrne HJ
Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29443901
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of PAMAM-coated gold nanoparticles in different unicellular models.
Perreault F; Melegari SP; Fuzinatto CF; Bogdan N; Morin M; Popovic R; Matias WG
Environ Toxicol; 2014 Mar; 29(3):328-36. PubMed ID: 22331655
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of autophagy protects against PAMAM dendrimers-induced hepatotoxicity.
Li Y; Zeng X; Wang S; Sun Y; Wang Z; Fan J; Song P; Ju D
Nanotoxicology; 2015 May; 9(3):344-55. PubMed ID: 24983897
[TBL] [Abstract][Full Text] [Related]
4. Toxicological assessment of third generation (G3) poly (amidoamine) dendrimers using the Allium cepa test.
Fernández Freire P; Peropadre A; Rosal R; Pérez Martín JM; Hazen MJ
Sci Total Environ; 2016 Sep; 563-564():899-903. PubMed ID: 26345251
[No Abstract] [Full Text] [Related]
5. Determination of spectral markers of cytotoxicity and genotoxicity using in vitro Raman microspectroscopy: cellular responses to polyamidoamine dendrimer exposure.
Efeoglu E; Casey A; Byrne HJ
Analyst; 2017 Oct; 142(20):3848-3856. PubMed ID: 28895594
[TBL] [Abstract][Full Text] [Related]
6. Carboxymethyl chitosan-poly(amidoamine) dendrimer core-shell nanoparticles for intracellular lysozyme delivery.
Zhang X; Zhao J; Wen Y; Zhu C; Yang J; Yao F
Carbohydr Polym; 2013 Nov; 98(2):1326-34. PubMed ID: 24053810
[TBL] [Abstract][Full Text] [Related]
7. Construction of Poly(amidoamine) Dendrimer/Carbon Dot Nanohybrids for Biomedical Applications.
Guo Y; Shen M; Shi X
Macromol Biosci; 2021 Apr; 21(4):e2100007. PubMed ID: 33615730
[TBL] [Abstract][Full Text] [Related]
8. Modification of the in vitro uptake mechanism and antioxidant levels in HaCaT cells and resultant changes to toxicity and oxidative stress of G4 and G6 poly(amidoamine) dendrimer nanoparticles.
Maher MA; Byrne HJ
Anal Bioanal Chem; 2016 Jul; 408(19):5295-307. PubMed ID: 27209595
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cationic polyamidoamine dendrimers' dermal toxicity in the rat skin model.
Winnicka K; Wroblewska M; Sosnowska K; Car H; Kasacka I
Drug Des Devel Ther; 2015; 9():1367-77. PubMed ID: 25834395
[TBL] [Abstract][Full Text] [Related]
10. Generation of intracellular reactive oxygen species and genotoxicity effect to exposure of nanosized polyamidoamine (PAMAM) dendrimers in PLHC-1 cells in vitro.
Naha PC; Byrne HJ
Aquat Toxicol; 2013 May; 132-133():61-72. PubMed ID: 23454648
[TBL] [Abstract][Full Text] [Related]
11. PAMAM dendrimer as a talented multifunctional biomimetic nanocarrier for cancer diagnosis and therapy.
Surekha B; Kommana NS; Dubey SK; Kumar AVP; Shukla R; Kesharwani P
Colloids Surf B Biointerfaces; 2021 Aug; 204():111837. PubMed ID: 33992888
[TBL] [Abstract][Full Text] [Related]
12. Charge affects the oral toxicity of poly(amidoamine) dendrimers.
Thiagarajan G; Greish K; Ghandehari H
Eur J Pharm Biopharm; 2013 Jun; 84(2):330-4. PubMed ID: 23419816
[TBL] [Abstract][Full Text] [Related]
13. Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids.
Bugno J; Hsu HJ; Pearson RM; Noh H; Hong S
Mol Pharm; 2016 Jul; 13(7):2155-63. PubMed ID: 26828309
[TBL] [Abstract][Full Text] [Related]
14. Effect of poly(amidoamine) dendrimers on the structure and activity of immune molecules.
Lin J; Hua W; Zhang Y; Li C; Xue W; Yin J; Liu Z; Qiu X
Biochim Biophys Acta; 2015 Feb; 1850(2):419-25. PubMed ID: 25463324
[TBL] [Abstract][Full Text] [Related]
15. Developmental toxicity of low generation PAMAM dendrimers in zebrafish.
Heiden TC; Dengler E; Kao WJ; Heideman W; Peterson RE
Toxicol Appl Pharmacol; 2007 Nov; 225(1):70-9. PubMed ID: 17764713
[TBL] [Abstract][Full Text] [Related]
16. Comparative toxicological assessment of PAMAM and thiophosphoryl dendrimers using embryonic zebrafish.
Pryor JB; Harper BJ; Harper SL
Int J Nanomedicine; 2014; 9():1947-56. PubMed ID: 24790436
[TBL] [Abstract][Full Text] [Related]
17. Effects of Polyamidoamine Dendrimers on a 3-D Neurosphere System Using Human Neural Progenitor Cells.
Zeng Y; Kurokawa Y; Zeng Q; Win-Shwe TT; Nansai H; Zhang Z; Sone H
Toxicol Sci; 2016 Jul; 152(1):128-44. PubMed ID: 27125967
[TBL] [Abstract][Full Text] [Related]
18. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
[TBL] [Abstract][Full Text] [Related]
19. Gene delivery efficiency and cytotoxicity of heterocyclic amine-modified PAMAM and PPI dendrimers.
Hashemi M; Tabatabai SM; Parhiz H; Milanizadeh S; Amel Farzad S; Abnous K; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():791-800. PubMed ID: 26838910
[TBL] [Abstract][Full Text] [Related]
20. Naked Poly(amidoamine) Dendrimer Nanoparticles Exhibit Intrinsic Embryotoxicity During the Early Stages of Normal Development.
Kheraldine H; Gupta I; Alhussain H; Jabeen A; Akhtar S; Al Moustafa AE; Rachid O
J Biomed Nanotechnol; 2020 Oct; 16(10):1454-1462. PubMed ID: 33422157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
